Retraction notice to "Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma" [Life Sci. 328 (2023) 121865]

Ghazaleh Khalili-Tanha¹, Hamid Fiuji¹, Masoumeh Gharib², Meysam Moghbeli¹, Nima Khalili-Tanha¹, Farzad Rahmani³, Neda Shakour⁴, Mina Maftooh¹, Seyed Mahdi Hassaniana⁵, Fereshteh Asgharzadeh⁶, Soodabeh Shahidsales⁷, Kazem Anvari⁷, M R Mozafari⁸, Gordon A Ferns⁹, Jyotsna Batra¹⁰, Elisa Giovannetti¹¹, Majid Khazaei¹², Amir Avan¹³

Affiliations

¹ Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
² Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
³ Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
⁴ Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
⁵ Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
⁶ Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
⁷ Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
⁸ Australasian Nanoscience and Nanotechnology Initiative (ANNI), 8054 Monash University LPO, Clayton, Victoria, Australia.
⁹ Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK.
¹⁰ School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Brisbane, QLD 4059, Australia; Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
¹¹ Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam U.M.C., VU. University Medical Center (VUMC), Amsterdam, the Netherlands; Cancer Pharmacology Lab, AIRC Start up Unit, Fondazione Pisana per La Scienza, Pisa, Italy.
¹² Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
¹³ Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Brisbane, QLD 4059, Australia; School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology, 2 George St, Brisbane City, QLD 4000, Australia.

PMID: 39419712
DOI: 10.1016/j.lfs.2024.123106

Retraction notice to "Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma" [Life Sci. 328 (2023) 121865]

Ghazaleh Khalili-Tanha et al. Life Sci. 2024.

. 2024 Dec 1:358:123106.

doi: 10.1016/j.lfs.2024.123106. Epub 2024 Oct 16.

Authors

Affiliations

¹ Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
² Department of Pathology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
³ Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
⁴ Department of Medicinal Chemistry, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
⁵ Department of Medical Biochemistry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
⁶ Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
⁷ Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
⁸ Australasian Nanoscience and Nanotechnology Initiative (ANNI), 8054 Monash University LPO, Clayton, Victoria, Australia.
⁹ Brighton & Sussex Medical School, Division of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK.
¹⁰ School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Brisbane, QLD 4059, Australia; Translational Research Institute, 37 Kent Street, Woolloongabba, QLD 4102, Australia.
¹¹ Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam U.M.C., VU. University Medical Center (VUMC), Amsterdam, the Netherlands; Cancer Pharmacology Lab, AIRC Start up Unit, Fondazione Pisana per La Scienza, Pisa, Italy.
¹² Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; Department of Physiology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
¹³ Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran; College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, Brisbane, QLD 4059, Australia; School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology, 2 George St, Brisbane City, QLD 4000, Australia.

PMID: 39419712
DOI: 10.1016/j.lfs.2024.123106

No abstract available

PubMed Disclaimer

Retraction of

Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma.
Khalili-Tanha G, Fiuji H, Gharib M, Moghbeli M, Khalili-Tanha N, Rahmani F, Shakour N, Maftooh M, Hassanian SM, Asgharzadeh F, Shahidsales S, Anvari K, Mozafari MR, Ferns GA, Batra J, Giovannetti E, Khazaei M, Avan A. Khalili-Tanha G, et al. Life Sci. 2023 Sep 1;328:121865. doi: 10.1016/j.lfs.2023.121865. Epub 2023 Jun 17. Life Sci. 2023. Retraction in: Life Sci. 2024 Dec 1;358:123106. doi: 10.1016/j.lfs.2024.123106. PMID: 37336360 Retracted.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Retraction notice to "Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma" [Life Sci. 328 (2023) 121865]

Affiliations

Retraction notice to "Dual targeting of TGF-β and PD-L1 inhibits tumor growth in TGF-β/PD-L1-driven colorectal carcinoma" [Life Sci. 328 (2023) 121865]

Authors

Affiliations

Retraction of

References

Publication types

LinkOut - more resources

Full Text Sources

Research Materials